Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for MACE prevention after bare metal stent placement
NCT00426049Phase 3Unknown
- Sponsor
- Deutsches Herzzentrum der Charité
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in coronary artery disease (CAD), coronary restenosis, sponsored by Deutsches Herzzentrum der Charité. Status: unknown.
02
Drugs
everolimus
03
Conditions
coronary artery disease (CAD)coronary restenosis
Beyond the preview
Go deeper on NCT00426049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426049.